Novartis
Search results
6 days ago · Alcon is also integrating DSLT into its Alcon Vision Suite ecosystem, working to ensure the ability to train and deliver the best-in-class service that its customers have come to expect. Additional information about plans and timing for launches in new markets will be provided in the future.
- About Alcon
1989 Launch of NewVue (Focus), Alcon’s first soft contact...
- Innovation
In 1981, Alcon set out to help support research in eye...
- Newsroom
Alcon's Social Impact and Sustainability strategy, as...
- Contact Us
U.S. Surgical. T 1 800 TO ALCON 1 800 862 5266 . Hours:...
- Search
Search - Alcon Completes Acquisition of BELKIN Vision,...
- Investors
Alcon helps people see brilliantly. As the global leader in...
- Alcon Research Institute
In 1981, Alcon set out to help support research in eye...
- Responsible Business Practice
Alcon is committed to demonstrating integrity in everything...
- About Alcon
3 days ago · Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives.
Jun 24, 2024 · Alcon has tested Unity VCS and Unity CS during investigational advisory wet lab sessions with more than 200 highly experienced surgeons from 30+ countries. Now with 510(k) clearance, Alcon will begin a thorough program to secure real-world feedback before commercial launch in 2025.
4 days ago · Alcon completed its takeover of glaucoma device developer Belkin Vision, the company said Monday. The deal, which is worth $81 million upfront and up to $385 million in milestone payments, gives ...
Jun 24, 2024 · GENEVA, June 24, 2024 -- ( BUSINESS WIRE )--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract...
5 days ago · The acquisition includes BELKIN Vision's Direct Selective Laser Trabeculoplasty (DSLT) technology, expanding Alcon's glaucoma portfolio with a first-line therapy. For glaucoma, Alcon also offers implantables such as Hydrus ® Microstent, and pharmaceutical drops that are currently available in the U.S.
Jun 25, 2024 · Alcon has received FDA 510 (k) clearance for its Unity Vitreoretinal Cataract System (VCS) and Unity Cataract System (CS), marking a significant advancement in surgical technology. These devices are the first offerings from Alcon's Unity portfolio, aimed at enhancing equipment solutions and consumables for cataract and vitreoretinal surgeries.
